ALB and fatty liver disease: Although we have found a reduction in hepatic steatosis after the treatment, it was not reflected in improvement of the liver biochemistry and platelet count, since AST, ALT, AP, GGT, bilirubin, albumin and platelet number did not change compared to the baseline values.